From the NIH: TORCH package antibody tests not recommended for routine screening of pregnant women

JAMA ◽  
1982 ◽  
Vol 247 (18) ◽  
pp. 2477-2478
2012 ◽  
Vol 17 (3) ◽  
Author(s):  
J M Munster ◽  
L M Steggerda ◽  
A C Leenders ◽  
J G Aarnoudse ◽  
E Hak

In Europe the incidence of human Q fever has dramatically increased over the previous years. Untreated infections with Coxiella burnetii, the causal agent of Q fever, have been associated with both obstetric and maternal complications. The majority of pregnant women with a C. burnetii infection remain asymptomatic, hence screening could be of value to prevent unwanted outcomes in this high-risk group. We applied the updated Wilson and Jungner criteria to review the evidence for routine screening for C. burnetii infection during pregnancy. Since much uncertainty remains about the incidence, clinical consequences, diagnostics and treatment of C. burnetii infection during pregnancy, routine screening for C. burnetii infection during pregnancy should not be recommended. Rigorous studies to assess the effectiveness of C. burnetii screening are warranted.


PEDIATRICS ◽  
1973 ◽  
Vol 52 (2) ◽  
pp. 302-303
Author(s):  
Hania W. Ris

Drs. Snowe and Wilfert's1 timely paper on epidemic reappearance of gonococcal ophthalmia neonatorum calls attention to a very serious problem. Recently in Wisconsin a case of gonococcal ophthalmia was reported2 in a 3-day-old infant who received silver nitrate prophylactic treatment. The prenatal care consisted of 14 visits to an obstetrician, which did not include screening for gonorrhea. The author's statement in the summary "gonorrhea occurs with significant frequency in obstetrical groups to merit attempts at therapy of the gravid mother" could be misinterpreted as advocating treatment without establishing a diagnosis.


PLoS ONE ◽  
2020 ◽  
Vol 15 (9) ◽  
pp. e0239887
Author(s):  
Pilar Díaz-Corvillón ◽  
Max Mönckeberg ◽  
Antonia Barros ◽  
Sebastián E. Illanes ◽  
Arturo Soldati ◽  
...  

1988 ◽  
Vol 16 (4) ◽  
pp. 197-204 ◽  
Author(s):  
Marie-Louise Sandén ◽  
Per Bjurulf

Serum-Alpha-Fetoprotein (se-AFP) screening is a controversial issue in Sweden. In some areas the test has never been offered, in others it is routinely offered to all pregnant women and there are areas where the se-AFP test has been offered but is no longer available but for very special indications. This pseudoexperimental situations was used to analyze the effects of different information environments on attitudes to and knowledge of testing procedures at the antenatal clinics, especially the se-AFP test, and anxiety of malformations. Consecutive series of pregnant women in these three areas filled in questionnaires at their first visit, in the 22nd to 24th, and the 32nd to 35th weeks of pregnancy, and after delivery. The attitudes to prenatal screening were most positive in the routine screening area and most negative in the area which previously but no longer offers the test. The level of knowledge was somewhat higher in the routine screening area at the first visit to the clinic and increased substantially, especially in the routine screening area.


2018 ◽  
Vol 57 (2) ◽  
Author(s):  
Tudor Rares Olariu ◽  
Brian G. Blackburn ◽  
Cindy Press ◽  
Jeanne Talucod ◽  
Jack S. Remington ◽  
...  

ABSTRACTThis study evaluated the usefulness of adding theToxoplasma gondiiIgA antibody enzyme-linked immunosorbent assay (ELISA) to the serologic panel of tests done for the diagnosis of acute toxoplasmosis in pregnant women in a reference laboratory in the United States. We conducted a retrospective study of 690 consecutive pregnant women with positiveT. gondiiIgG antibody test results who also hadT. gondiiIgA and IgM antibody tests performed. Patients were defined as acutely or chronically infected withT. gondiibased on a panel of serologic tests performed at the Palo Alto Medical Foundation Toxoplasma Serology Laboratory (PAMF-TSL). Among the 81 women who were positive byT. gondiiIgA antibody ELISA testing, 61 (75.3%) were acutely infected withT. gondii, while of the 547 who were negative by IgA testing, only 24 (4.4%) were acutely infected (P < 0.001). Among the 71 women who were positive by both IgA and IgM antibody tests, 61 (85.9%) were acutely infected, whereas 24 (19.2%) of the 125 women who were positive by only the IgM ELISA were acutely infected (P < 0.001). These results demonstrate that pregnant women withT. gondiiIgA antibodies are more likely than pregnant women withoutT. gondiiIgA antibodies to have had a recent infection withT. gondii.ToxoplasmaIgA antibody testing can therefore improve the accuracy of a serologic panel for the diagnosis of acute toxoplasmosis during pregnancy. Physicians who ordered testing only forT. gondiiIgG and IgM should also request additional testing for IgA and IgG avidity, if both IgG and IgM are positive. This further testing should, ideally, be performed in a reference laboratory.


Author(s):  
Kaliki Hymavathi ◽  
Malini Devi Gottipati ◽  
Tejaswini Jakka ◽  
Bhavana T. C.

Background: Thyroid dysfunction is commonly seen in pregnant women causing adverse maternal and fetal effects. Routine screening of antenatal population for the same will be helpful for successful pregnancy outcomes. The objective of this study is to detect and treat antenatal women with Thyroid dysfunction to avoid deleterious maternal/ fetal effects.Methods: The present study is a hospital based prospective study conducted in the department of Obstetrics and Gynaecology of Narayana Medical College and Hospital(NMCH), Nellore, Andhra Pradesh, India. 1000 pregnant women were randomly recruited into this study. Apart from routine antenatal investigations, Thyroid function tests (TFT) - Thyroid stimulating hormone (TSH), freeT4 (fT4) and Thyroid peroxidase antibody (TPO Ab) are done for all the recruited women at the first visit of antenatal booking and individual Thyroid tests are repeated as required.Results: Following the TFT the study population is classified into pregnancies with euthyroidism‚ subclinical/ overt hypothyroidism and hyperthyroidism. The prevalence of Thyroid disorders in present study was 12.7% of which hypothyroidism noted in 10.3% (subclinical 6.9% and overt 3.4%) while hyperthyroidism seen in 2.4% (subclinical 1.8% and overt 0.6%). The various pregnancy complications, labour and neonatal outcomes have been analyzed.Conclusions: Thyroid dysfunction in pregnancy affects the health of the mother as well as the baby. Screening for Thyroid dysfunction should be performed as part of the routine antenatal work-up for successful pregnancy outcomes.


Sign in / Sign up

Export Citation Format

Share Document